Daily aspirin offers little to no benefit for most adults trying to prevent heart disease, new report says
How hospitals and health systems can help patients avoid medical debt
‘Without a word for what we know’: The unfathomable loss of a million U.S. Covid deaths
For kids with Down syndrome, a new device offers hope for treating difficult sleep problems
Health systems are using machine learning to predict high-cost care. Will it help patients?
At small and rural hospitals, ransomware attacks are causing unprecedented crises
Averting the looming purge of people from Medicaid
A new crop of companies is reshaping the health data economy
Listen: Should gender dysphoria be a required stop en route to gender euphoria?
Home care instead of hospital care: Congress should extend a crucial waiver
When a dire text message interrupted his talk, this doctor’s cancer research became painfully real
Hospital prices are soaring especially fast in Northern California. Here’s why
As research grows on primary care and serious mental illness, a glaring gap remains
Afghan refugees, grappling with grief and trauma, face barriers to mental health care
Private equity, health care, and profits: It’s time to protect patients
A controversial proposal before the World Trade Organization to waive patent rights for Covid-19...
What could go wrong when pharmaceutical company shareholders and investors shape the public health...
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing...
For decades, the Food and Drug Administration has relied on outside expert panels for...
A United Nations committee urged wealthy nations to support a proposal before the World...
Online pharmacy startups have pledged to make it faster and easier than ever to...
The California Board of Pharmacy fined OptumRx, one of the largest pharmacy benefit managers...
Biogen, fresh off major decisions on CEO and Aduhelm, faces next hurdles
Biogen to replace CEO as it ‘substantially’ curbs spending on its Alzheimer’s drug
FDA suspends early study of Vertex stem-cell therapy for type 1 diabetes
Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic
Biogen board slashes CEO’s bonus as Aduhelm sales and overall business struggle
Up and down the ladder: The latest comings and goings
Startups are turning to a century-old technology to fuel a resurgence in neuro drug development
Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum
How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
A company developing a human blood substitute attempts a comeback, but IPO plans look dicey
Clinicians walk a tightrope when trying to help their patients with chronic pain. They want to be able to ease a patient’s...
When medical professionals think they’re seeing something new, or an unusual spike in cases of something known, disease detectives — epidemiologists —...
Online pharmacy startups have pledged to make it faster and easier than ever to get needed medications. But a high-profile series of...
LOS ANGELES — In the most extensive public comments about the stewardship of the Bill & Melinda Gates Foundation since the founders...
Listen: How should doctors treat chronic pain in the wake of the opioid crisis?
With usual suspects ruled out, disease detectives try to crack mystery of viral hepatitis cases in kids
A clash over online Adderall prescriptions is raising new questions about telehealth
Truepill halts Adderall prescriptions, heart algorithm taps Apple Watch data, and home health sees a goldrush
Biogen, fresh off major decisions on CEO and Aduhelm, faces next hurdles
A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
Global health should not be determined by pharma investors and shareholders
The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids
Pharmalittle: Biogen CEO exits amid Aduhelm failures; FDA eschews its own outside expert panels
Biogen to replace CEO as it ‘substantially’ curbs spending on its Alzheimer’s drug
The roots of burnout start early. See: Applying to medical school
Medicare at 60 would have harmful unintended consequences
More uniformly infectious, more treatable, more genetically predictable: How coronavirus is getting closer to flu
Early cancer-detection market heats up as Guardant Health launches colon cancer test
Is the FDA taking advice from its expert panels? A new analysis points to inconsistencies in the process
U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines
The brain ‘learns’ to have seizures more efficiently and frequently over time, mouse study shows
FDA suspends early study of Vertex stem-cell therapy for type 1 diabetes
Pharmalittle: FDA declines to approve two more drugs tested in China; Pfizer Covid pill fails to prevent infection in household members
Paxlovid’s failure as a preventative measure raises questions, but doctors still back it as a therapeutic
Substituting genetic ancestry for race in research? Not so fast
Listen: ‘Birthing while Black’ is an American crisis. Communities demand justice
Meet the lawmakers and lobbyists who want to bring health tech into the home
Hundreds of families share a lethal inheritance. This kidney researcher hopes to break the chain
Can we take a bath during fever?
An algorithm that analyzes Apple Watch data shows early promise in detecting heart problems
Beyond awareness: The medical system needs to deeply reform its care of people with autism
Labor costs from Omicron surge drag Ascension into the red
